Sentences with phrase «stage breast cancer patients»

Researchers found that shorter course of radiation therapy may provide lesser side effects for early stage breast cancer patients compared to the long - term treatments.

«This study demonstrates that Prosigna can reliably identify early stage breast cancer patients who have a low risk - of disease recurrence at 10 years, including a substantial proportion of patients with node - positive disease for whom the risk / benefit derived for adjuvant chemotherapy would be at best neutral,» said Dr. Alessandra Cesano, chief medical officer of NanoString Technologies.

According to Dr. Gass, «In an era where we see more early - staged breast cancer patients choosing mastectomy, no study has previously addressed breast specific sensuality, defined as the breast's role during intimacy.

Not exact matches

The trial has also included 10 HER -2-negative breast cancer patients, all of them in early stages of the disease.

While one drug, MEK inhibitor, is usually used in advanced - stage melanoma, the other drug, CDK4 / 6 inhibitor, palbociclib, is currently FDA - approved for treatment of Estrogen Receptor - positive breast cancer patients.

An analysis of nearly 273,000 patients showed that between 2013 and 2014 there was a 1 % increase in the percentage of breast, lung, and colorectal cancers diagnosed at the earliest, most treatable stage.

Therefore, screening could result in over-treatment and consequently in decreased quality of life and ability to function in older breast cancer patients, without lowering the incidence of advanced stage breast cancer or deaths from the disease,» he said.

Prior studies that examined the impact of cancer treatment decisions on employment showed that patients who received chemotherapy were most likely to experience longer disruptions in or loss of employment, but changes in breast cancer management in recent years have shifted recommendations away from chemotherapy for early stage breast cancer.

Dr. Sparano continued: «This is the first prospectively conducted clinical trial evaluating this assay — or any multigene expression assay for that matter — in which patients with early stage breast cancer were uniformly treated based on their assay results.

The findings provide the highest level of evidence supporting expert - derived clinical practice guidelines which have recommended Oncotype DX in patients with early stage ER - positive breast cancer.

«The compelling results seen in this global study provide unequivocal evidence supporting the clinical utility of Oncotype DX to risk - stratify patients with early stage breast cancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medcancer, and indicate that the findings are generalizable to everyday clinical practice,» said lead author Joseph A. Sparano, MD, vice-chairman of medical oncology at Montefiore Einstein Center for Cancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of MedCancer Care, and professor of medicine and of obstetrics, gynecology, women's health at Albert Einstein College of Medicine.

Since small, early - stage cancers are the most responsive to drug treatments, screening is an important aspect of follow - up care for breast cancer patients, and early detection is critical in tailoring appropriate and effective therapeutic interventions.

«We are evaluating patient and disease factors that affect the value of FDG PET / CT for systemic staging of locally advanced breast cancer,» said study coauthor Molly Parsons.

This shows promise for breast cancer patients as diagnosing and treating the breast cancer at early stages means there is a greater chance of preventing cancer cells spreading to other tissues, such as the lungs, brain and bone.

A study done by researchers at Fox Chase Cancer Center shows that many relatives of patients who undergo testing for a gene linked to breast and ovarian cancers misinterpret the results, and less than half of those who could benefit from genetic testing say they plan to get tested themselves — despite the fact that knowing your genetic status may help catch the disease in its earliest stages.

Appropriate patients with early stage breast cancer should not opt for less than this standard in care if properly educated,» Black continues.

In early - stage premenopausal breast cancer, for example, 10 - year survival rates were 68 % for African Americans versus 77 % for all other patients (mostly Caucasian) in the trials.

«These results have driven us to update our treatment guidelines in Denmark to include testing with Prosigna as part of the workup of postmenopausal women with early stage HR - positive / Her -2 negative breast cancer, including patients with node - positive disease.»

Though trastuzumab and pertuzumab have increased response rates and improved outcomes in HER2 - positive breast cancer, 30 % to 40 % of early - stage patients treated in the neoadjuvant setting will have residual disease at the time of surgery.

The authors built a statistical simulation model to estimate the 25 - year incremental costs per quality - adjusted life - year (QALY) for Oncotype DX testing in order to evaluate the cost - effectiveness of GEP testing among patients with early - stage ER - positive / HER2 - negative breast cancer treated in community oncology practices.

The trial included 2,176 patients with early - stage HER2 - positive breast cancer and randomly assigned them to 9 - weeks trastuzumab or 12 - months trastuzumab.

The morphological assessment of the differentiation degree in breast cancer has been provided useful prognostic information and the histological grade forms part of the multifactor Nottingham prognostic index together with tumor size and lymph node stage, which is used to assure individual patient for proper therapy [17].

About 40 percent of the young cancer patients were diagnosed with what's known as stage two tumors, when cancer has spread to lymph nodes surrounding the breast while just 34 percent of older women were diagnosed when cancer had reached stage two.

For example, the translational laboratory is providing support to a precision medicine - based clinical trial for patients with early - stage, triple - negative breast cancer.

We know that far too many patients with curable cancers if they are caught at earlier stage, colon cancer, breast cancer, cervical cancer, these cancers are still detected late when they are less amenable to curative treatments.

Uninsured women with breast cancer were nearly 2.6 times more likely to have a late - stage diagnosis than cancer patients who were insured, finds a new study from the Brown School at Washington University in St. Louis.

Uninsured women with breast cancer were nearly 2.6 times more likely to have a late stage diagnosis than cancer patients who were insured, finds a new study from Kimberly Johnson, associate professor at the Brown School.

It's normal to start thinking of your most comforting casserole recipes to drop off at the home of someone with breast cancer, but «people do not realize that a lot of patients may have foods that they can not eat,» says Rebecca Scheinkman, 36, who was diagnosed in 2014 with stage 4 breast cancer.

For the study, 191 stage 0 to 3 breast cancer patients were randomized to 1 of 3 groups: yoga, basic stretching, or neither.

Breast cancer treatment regimens differ widely based on the type of cancer, its stage, its sensitivity to hormones, the patient's age and health, and other factors.

If you're a close friend or family member, wanting to know the stage of a patient's breast cancer is understandable.

Patients diagnosed with inflammatory breast cancer may receive a combination of treatment measures, depending on the stage of their condition.

The five - year survival rate reduces * to approximately 93 % amongst patients that are diagnosed with stage two breast cancer and the five - year survival rate for patients with stage three breast cancer is 72 %.

This study recruited patients with Stages 0 to III breast cancer prior to starting radiotherapy.

Diagnosing breast cancer while it's still in stage 1 can improve patients» prognosis and reduce the need for intensive and costly treatments, the study authors wrote in the journal Cancer Epidemicancer while it's still in stage 1 can improve patients» prognosis and reduce the need for intensive and costly treatments, the study authors wrote in the journal Cancer EpidemiCancer Epidemiology.

Early Stage Breast Cancer Support Sisters Meet others diagnosed with breast cancer, share and learn coping techniques, facilitated by patient navigBreast Cancer Support Sisters Meet others diagnosed with breast cancer, share and learn coping techniques, facilitated by patient navigCancer Support Sisters Meet others diagnosed with breast cancer, share and learn coping techniques, facilitated by patient navigbreast cancer, share and learn coping techniques, facilitated by patient navigcancer, share and learn coping techniques, facilitated by patient navigators.

For patients with stage 4 breast cancer, their only option is going to be a guaranteed issue policy, and they'll have to survive at least two years before the death benefit will be available.

The campus» Assistant Director of Education, Pam Kowalski, shared information on the stages of cancer, testing and treatment options for patients diagnosed with breast cancer.

Tags for this Online Resume: Biotechnology, Diagnostic, Pharmaceutical, Marketing, Oncology, Strategy, Brand Planning, Global Marketing, New Product Planning, Pricing, Market Research, Brand Leader, Commercial, Commercialization, Launch, Drug Development, Matrix, Cross Functional, Digital, KOL, Key Opinion Leader, Portfolio, Management, Brand Team, Agency, Diabetes, Cardiovascular, Commercial Strategy, Corporate Affairs, Communications, Hematology, Urology, Neuroscience, phase 2, phase 3, phase II, phase III, Powerpoint, Excel, Word, Part B, Part D, Seattle, Portland, San Francisco, Executive Director, Senior Director, Director, Vice President, Go - To - Market, Value Proposition, Go To Market, Launch Planning, Access, Reimbursement, Payer, Market Development, Market Assessment, Pipeline, In - Line, Brand Management, Coaching, Leadership, Marketing Strategies, Marketing Strategy, Strategic Planning, Autoimmune, Early Stage, Pre-Launch, Pre Launch, Regulatory, Operations, Marketing Plan, Business Plan, Business Development, Market Analysis, Segmentation, Targeting, Companion Diagnostic, Target Product Profile, Pre-Clinical, Competition, Positoning, Branding, Sales, Budget, Sales Management, Communication Plan, Publication Plan, Project Management, Genetic, Genomic, Lifecycle, Long Range, Device, Late Stage, Direct Report, Indirect Report, New Molecular Entities, Competitive, Biopharmaceutical, Medical Device, Non-Promotional, Tactical, Execution, IND, Revenue, Partner, Clinical, Consult, Analytical, Problem Solver, Global, International, Affordable Care Act, Lymphoma, Leukemia, Prostate, Breast, Cancer, OPDP, Promotional, Promotions, Brand, Healthcare, Distribution, Infrastructure, IMS, Priority Review, Experienced, Patient, Consumer

Evidence - based recommendations report that 83 per cent of breast cancer patients should receive radiotherapy at some stage during their illness.

This Teachable Moment uses the case of a woman in her 30s undergoing chemotherapy for stage 2A breast cancer who was hospitalized for febrile neutropenia to illustrate the need to avoid overtreatment for low - risk patients with this common oncological complication.